Cryo-Cell International Inc
AMEX:CCEL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Cryo-Cell International Inc
Other Liabilities
Cryo-Cell International Inc
Other Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Cryo-Cell International Inc
AMEX:CCEL
|
Other Liabilities
$52.4m
|
CAGR 3-Years
11%
|
CAGR 5-Years
12%
|
CAGR 10-Years
15%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Other Liabilities
$1.5B
|
CAGR 3-Years
5%
|
CAGR 5-Years
2%
|
CAGR 10-Years
11%
|
|
|
CVS Health Corp
NYSE:CVS
|
Other Liabilities
$25.1B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
32%
|
|
|
Cigna Corp
NYSE:CI
|
Other Liabilities
$21.7B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Other Liabilities
$1.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
2%
|
CAGR 10-Years
15%
|
|
|
Guardant Health Inc
NASDAQ:GH
|
Other Liabilities
$306.2m
|
CAGR 3-Years
12%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
Cryo-Cell International Inc
Glance View
Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. The company is headquartered in Oldsmar, Florida and currently employs 83 full-time employees. The firm operates through three segments: The cellular processing and cryogenic storage of umbilical cord blood and cord tissue stem cells for family use; the manufacture of PrepaCyte CB units, the processing technology used to process umbilical cord blood stem cells, and the cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives and other related healthcare professionals. The Company, in combination with its global affiliates, stores approximately 500,000 cord blood and cord tissue specimens around the world for the benefit of newborn babies and possibly other members of their families. Its processing and storage of specimens is handled from its facility in Oldsmar, Florida.
See Also
What is Cryo-Cell International Inc's Other Liabilities?
Other Liabilities
52.4m
USD
Based on the financial report for Nov 30, 2025, Cryo-Cell International Inc's Other Liabilities amounts to 52.4m USD.
What is Cryo-Cell International Inc's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
15%
Over the last year, the Other Liabilities growth was 9%. The average annual Other Liabilities growth rates for Cryo-Cell International Inc have been 11% over the past three years , 12% over the past five years , and 15% over the past ten years .
